Why 'No Market Need' Stays the Top Failure Cause

CB Insights found 42% of failed startups cited no market need in 2014, and 43% showed poor product-market fit in 2026. The cause is sequence, not execution.

By Harinderpal Hanspal on June 2026. Updated October 2026

CB Insights' 2014 analysis of 101 failed startups found that 42% cited no market need. Its March 2026 review of 431 venture-backed companies that shut down since 2023 found poor product-market fit behind 43% of the 385 whose failure reasons could be identified. The 2014 count includes every reason cited and the 2026 count one primary reason per company, so they are not a precise time series. The stability is still hard to ignore.

The share of failures rooted in the market barely moved from 42% in 2014 to 43% in 2026 Two horizontal bars on a zero to fifty percent scale: 42% of 101 failed startups cited no market need in 2014, and poor product-market fit was behind 43% of the 385 shutdowns with a known cause in 2026. 0% 25% 50% SHARE OF FAILURES TRACED TO THE MARKET 2014 CB Insights, 101 failed startups: no market need 42% 2026 CB Insights, 385 shutdowns with a known cause: poor product-market fit 43% Tooling, talent, capital and playbooks improved. The share stayed where it was. The two studies measure slightly different things, so this is not a precise time series.
The share of failures rooted in the market barely moved from 42% in 2014 to 43% in 2026

In our reading, tooling, talent, capital and playbooks all improved over that decade, and the share of failures rooted in the market stayed where it was. That points to sequencing. The commercial hypothesis gets formed, funded and acted on before anyone tests it, and no downstream excellence fixes an untested upstream assumption.

For a technology company selling into industrial buyers, the lesson is about specifics. In our reading, few failed ventures lacked market need in the loose sense. What was missing was need at the level of one buyer, their urgency, the price, the channel and the approval process. The loose version of a hypothesis survives every friendly conversation. The specific version can be proven wrong, and testing it is what separates market validation from market enthusiasm.

The AI wave follows the same order. Gartner expects more than 40% of agentic AI projects to be canceled by the end of 2027, citing escalating costs, unclear business value or inadequate risk controls.

Go deeper: Pilot purgatory and the Stop verdict sets out the pattern. The page for technology companies shows how we test the specifics before a go-to-market commitment.